Barely Significant
← all excerpts

Immunotherapy for Treatment of Pleural Mesothelioma: Current and Emerging Therapeutic Strategies.

Int J Mol Sci · 2024 · PMC11477297 · PMID 39409190

Europe PMCDOI
1
hedged sentence
0.2000
closest p · 4.0× alpha
0.2000
boldest claim

The sentences

did not reach statistical significancep = 0.20not close (p > 0.1)
No safety concerns were identified, and the study demonstrated a trend towards superior PFS that did not reach statistical significance due to lack of power (12.2 months or ADC combined with pembrolizumab versus 3.9 months for single-agent pembrolizumab; HR 0.55, p = 0.20).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.